TY - JOUR AU - Orditura, M. PY - 2014 DA - 2014// TI - Treatment of gastric cancer JO - World J Gastroenterol VL - 20 UR - https://doi.org/10.3748/wjg.v20.i7.1635 DO - 10.3748/wjg.v20.i7.1635 ID - Orditura2014 ER - TY - JOUR AU - Hayashi, M. PY - 2008 DA - 2008// TI - High expression of HER3 is associated with a decreased survival in gastric cancer JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-08-1064 DO - 10.1158/1078-0432.CCR-08-1064 ID - Hayashi2008 ER - TY - JOUR AU - Koizumi, W. PY - 2008 DA - 2008// TI - S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial JO - Lancet Oncol VL - 9 UR - https://doi.org/10.1016/S1470-2045(08)70035-4 DO - 10.1016/S1470-2045(08)70035-4 ID - Koizumi2008 ER - TY - JOUR AU - Schlessinger, J. AU - Lemmon, M. A. PY - 2006 DA - 2006// TI - Nuclear signaling by receptor tyrosine kinases: the first robin of spring JO - Cell VL - 127 UR - https://doi.org/10.1016/j.cell.2006.09.013 DO - 10.1016/j.cell.2006.09.013 ID - Schlessinger2006 ER - TY - JOUR AU - Moghbeli, M. PY - 2013 DA - 2013// TI - Association of PYGO2 and EGFR in esophageal squamous cell carcinoma JO - Med Oncol VL - 30 UR - https://doi.org/10.1007/s12032-013-0516-9 DO - 10.1007/s12032-013-0516-9 ID - Moghbeli2013 ER - TY - JOUR AU - Zwick, E. AU - Bange, J. AU - Ullrich, A. PY - 2002 DA - 2002// TI - Receptor tyrosine kinases as targets for anticancer drugs JO - Trends Mol Med VL - 8 UR - https://doi.org/10.1016/S1471-4914(01)02217-1 DO - 10.1016/S1471-4914(01)02217-1 ID - Zwick2002 ER - TY - JOUR AU - Buzdar, A. U. PY - 2005 DA - 2005// TI - Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.07.032 DO - 10.1200/JCO.2005.07.032 ID - Buzdar2005 ER - TY - JOUR AU - Carpenter, G. PY - 1987 DA - 1987// TI - Receptors for epidermal growth factor and other polypeptide mitogens JO - Annu Rev Biochem VL - 56 UR - https://doi.org/10.1146/annurev.bi.56.070187.004313 DO - 10.1146/annurev.bi.56.070187.004313 ID - Carpenter1987 ER - TY - JOUR AU - Cho, H. S. PY - 2003 DA - 2003// TI - Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab JO - Nature VL - 421 UR - https://doi.org/10.1038/nature01392 DO - 10.1038/nature01392 ID - Cho2003 ER - TY - JOUR AU - Joensuu, H. PY - 2009 DA - 2009// TI - Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: final results of the FinHer Trial JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.21.4577 DO - 10.1200/JCO.2008.21.4577 ID - Joensuu2009 ER - TY - JOUR AU - Piccart-Gebhart, M. J. PY - 2005 DA - 2005// TI - Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMoa052306 DO - 10.1056/NEJMoa052306 ID - Piccart-Gebhart2005 ER - TY - JOUR AU - Yarden, Y. AU - Sliwkowski, M. X. PY - 2001 DA - 2001// TI - Untangling the ErbB signalling network JO - Nat Rev Mol Cell Biol VL - 2 UR - https://doi.org/10.1038/35052073 DO - 10.1038/35052073 ID - Yarden2001 ER - TY - JOUR AU - Yarden, Y. PY - 2001 DA - 2001// TI - The EGFR family and its ligands in human cancer signalling mechanisms and therapeutic opportunities JO - Eur J Cancer VL - 37 UR - https://doi.org/10.1016/S0959-8049(01)00230-1 DO - 10.1016/S0959-8049(01)00230-1 ID - Yarden2001 ER - TY - JOUR AU - Hynes, N. E. AU - Lane, H. A. PY - 2005 DA - 2005// TI - ERBB receptors and cancer: the complexity of targeted inhibitors JO - Nat Rev Cancer VL - 5 UR - https://doi.org/10.1038/nrc1609 DO - 10.1038/nrc1609 ID - Hynes2005 ER - TY - JOUR AU - Massie, C. AU - Mills, I. G. PY - 2006 DA - 2006// TI - The developing role of receptors and adaptors JO - Nat Rev Cancer VL - 6 UR - https://doi.org/10.1038/nrc1882 DO - 10.1038/nrc1882 ID - Massie2006 ER - TY - JOUR AU - Cappuzzo, F. PY - 2005 DA - 2005// TI - Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer JO - J Natl Cancer Inst VL - 97 UR - https://doi.org/10.1093/jnci/dji112 DO - 10.1093/jnci/dji112 ID - Cappuzzo2005 ER - TY - JOUR AU - Hirsch, F. R. PY - 2003 DA - 2003// TI - Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.11.069 DO - 10.1200/JCO.2003.11.069 ID - Hirsch2003 ER - TY - JOUR AU - Ishitoya, J. PY - 1989 DA - 1989// TI - Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck JO - Br J Cancer VL - 59 UR - https://doi.org/10.1038/bjc.1989.113 DO - 10.1038/bjc.1989.113 ID - Ishitoya1989 ER - TY - JOUR AU - Kimura, M. PY - 2004 DA - 2004// TI - A proposal for diagnostically meaningful criteria to classify increased epidermal growth factor receptor and c-erbB-2 gene copy numbers in gastric carcinoma, based on correlation of fluorescence in situ hybridization and immunohistochemical measurements JO - Virchows Arch VL - 445 UR - https://doi.org/10.1007/s00428-004-1048-7 DO - 10.1007/s00428-004-1048-7 ID - Kimura2004 ER - TY - JOUR AU - Kimura, M. PY - 2005 DA - 2005// TI - Usefulness and limitation of multiple endoscopic biopsy sampling for epidermal growth factor receptor and c-erbB-2 testing in patients with gastric adenocarcinoma JO - Jpn J Clin Oncol VL - 35 UR - https://doi.org/10.1093/jjco/hyi089 DO - 10.1093/jjco/hyi089 ID - Kimura2005 ER - TY - JOUR AU - Lemoine, N. R. PY - 1991 DA - 1991// TI - Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer JO - Br J Cancer VL - 64 UR - https://doi.org/10.1038/bjc.1991.243 DO - 10.1038/bjc.1991.243 ID - Lemoine1991 ER - TY - JOUR AU - Perez, E. A. PY - 2001 DA - 2001// TI - The role of adjuvant monoclonal antibody therapy for breast cancer: rationale and new studies JO - Curr Oncol Rep VL - 3 UR - https://doi.org/10.1007/s11912-001-0073-9 DO - 10.1007/s11912-001-0073-9 ID - Perez2001 ER - TY - JOUR AU - Shia, J. PY - 2005 DA - 2005// TI - Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization study JO - Mod Pathol VL - 18 UR - https://doi.org/10.1038/modpathol.3800417 DO - 10.1038/modpathol.3800417 ID - Shia2005 ER - TY - JOUR AU - Wang, K. L. PY - 2007 DA - 2007// TI - Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome JO - Cancer VL - 109 UR - https://doi.org/10.1002/cncr.22445 DO - 10.1002/cncr.22445 ID - Wang2007 ER - TY - JOUR AU - Wang, X. PY - 2007 DA - 2007// TI - Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-2167 DO - 10.1158/1078-0432.CCR-06-2167 ID - Wang2007 ER - TY - JOUR AU - Reschke, M. PY - 2008 DA - 2008// TI - HER3 is a determinant for poor prognosis in melanoma JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-08-0186 DO - 10.1158/1078-0432.CCR-08-0186 ID - Reschke2008 ER - TY - JOUR AU - Sanidas, E. E. PY - 1993 DA - 1993// TI - Expression of the c-erbB-3 gene product in gastric cancer JO - Int J Cancer VL - 54 UR - https://doi.org/10.1002/ijc.2910540612 DO - 10.1002/ijc.2910540612 ID - Sanidas1993 ER - TY - JOUR AU - Sithanandam, G. PY - 2005 DA - 2005// TI - Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549 JO - Oncogene VL - 24 UR - https://doi.org/10.1038/sj.onc.1208381 DO - 10.1038/sj.onc.1208381 ID - Sithanandam2005 ER - TY - JOUR AU - Soler, M. PY - 2009 DA - 2009// TI - HER3 is required for the maintenance of neuregulin-dependent and -independent attributes of malignant progression in prostate cancer cells JO - Int J Cancer VL - 125 UR - https://doi.org/10.1002/ijc.24651 DO - 10.1002/ijc.24651 ID - Soler2009 ER - TY - JOUR AU - Tanner, B. PY - 2006 DA - 2006// TI - ErbB-3 predicts survival in ovarian cancer JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.04.8397 DO - 10.1200/JCO.2005.04.8397 ID - Tanner2006 ER - TY - JOUR AU - Slesak, B. PY - 1998 DA - 1998// TI - Expression of epidermal growth factor receptor family proteins (EGFR, c-erbB-2 and c-erbB-3) in gastric cancer and chronic gastritis JO - Anticancer Res VL - 18 ID - Slesak1998 ER - TY - JOUR AU - Witton, C. J. PY - 2003 DA - 2003// TI - Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer JO - J Pathol VL - 200 UR - https://doi.org/10.1002/path.1370 DO - 10.1002/path.1370 ID - Witton2003 ER - TY - JOUR AU - Yi, E. S. PY - 1997 DA - 1997// TI - High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas JO - Mod Pathol VL - 10 ID - Yi1997 ER - TY - JOUR AU - Wallasch, C. PY - 1995 DA - 1995// TI - Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3 JO - EMBO J VL - 14 UR - https://doi.org/10.1002/j.1460-2075.1995.tb00101.x DO - 10.1002/j.1460-2075.1995.tb00101.x ID - Wallasch1995 ER - TY - JOUR AU - Ambrosio, M. R. PY - 2016 DA - 2016// TI - Carbonic anhydrase IX is a marker of hypoxia and correlates with higher Gleason scores and ISUP grading in prostate cancer JO - Diagn Pathol VL - 11 UR - https://doi.org/10.1186/s13000-016-0495-1 DO - 10.1186/s13000-016-0495-1 ID - Ambrosio2016 ER - TY - JOUR AU - Vergara-Lluri, M. E. PY - 2012 DA - 2012// TI - High concordance between HercepTest immunohistochemistry and ERBB2 fluorescence in situ hybridization before and after implementation of American Society of Clinical Oncology/College of American Pathology 2007 guidelines JO - Mod Pathol VL - 25 UR - https://doi.org/10.1038/modpathol.2012.93 DO - 10.1038/modpathol.2012.93 ID - Vergara-Lluri2012 ER - TY - JOUR AU - Moghbeli, M. PY - 2014 DA - 2014// TI - Role of hMLH1 and E-cadherin promoter methylation in gastric cancer progression JO - J Gastrointest Cancer VL - 45 UR - https://doi.org/10.1007/s12029-013-9548-9 DO - 10.1007/s12029-013-9548-9 ID - Moghbeli2014 ER - TY - JOUR AU - Mayer, A. PY - 1993 DA - 1993// TI - The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer JO - Cancer VL - 71 UR - https://doi.org/3.0.CO;2-2 DO - 3.0.CO;2-2 ID - Mayer1993 ER - TY - JOUR AU - Moutinho, C. PY - 2008 DA - 2008// TI - Epidermal growth factor receptor structural alterations in gastric cancer JO - BMC Cancer VL - 8 UR - https://doi.org/10.1186/1471-2407-8-10 DO - 10.1186/1471-2407-8-10 ID - Moutinho2008 ER - TY - JOUR AU - Kim, M. A. PY - 2008 DA - 2008// TI - EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number JO - Histopathology VL - 52 UR - https://doi.org/10.1111/j.1365-2559.2008.03021.x DO - 10.1111/j.1365-2559.2008.03021.x ID - Kim2008 ER - TY - JOUR AU - Lieto, E. PY - 2008 DA - 2008// TI - Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients JO - Ann Surg Oncol VL - 15 UR - https://doi.org/10.1245/s10434-007-9596-0 DO - 10.1245/s10434-007-9596-0 ID - Lieto2008 ER - TY - JOUR AU - Kim, J. S. PY - 2009 DA - 2009// TI - Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival JO - Br J Cancer VL - 100 UR - https://doi.org/10.1038/sj.bjc.6604936 DO - 10.1038/sj.bjc.6604936 ID - Kim2009 ER - TY - JOUR AU - Galizia, G. PY - 2007 DA - 2007// TI - Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery JO - World J Surg VL - 31 UR - https://doi.org/10.1007/s00268-007-9016-4 DO - 10.1007/s00268-007-9016-4 ID - Galizia2007 ER - TY - JOUR AU - Mammano, E. PY - 2006 DA - 2006// TI - Epidermal growth factor receptor (EGFR): mutational and protein expression analysis in gastric cancer JO - Anticancer Res VL - 26 ID - Mammano2006 ER - TY - JOUR AU - Elebro, J. PY - 2016 DA - 2016// TI - Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1, 2 and 3 in Periampullary Adenocarcinoma JO - PLoS ONE VL - 11 UR - https://doi.org/10.1371/journal.pone.0153533 DO - 10.1371/journal.pone.0153533 ID - Elebro2016 ER - TY - JOUR AU - Terashima, M. PY - 2012 DA - 2012// TI - Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-12-1318 DO - 10.1158/1078-0432.CCR-12-1318 ID - Terashima2012 ER - TY - JOUR AU - Sergina, N. V. PY - 2007 DA - 2007// TI - Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3 JO - Nature VL - 445 UR - https://doi.org/10.1038/nature05474 DO - 10.1038/nature05474 ID - Sergina2007 ER - TY - JOUR AU - Maurer, C. A. PY - 1998 DA - 1998// TI - Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2 JO - Hum Pathol VL - 29 UR - https://doi.org/10.1016/S0046-8177(98)90444-0 DO - 10.1016/S0046-8177(98)90444-0 ID - Maurer1998 ER - TY - JOUR AU - Abd El-Rehim, D. M. PY - 2004 DA - 2004// TI - Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma JO - Br J Cancer VL - 91 UR - https://doi.org/10.1038/sj.bjc.6602184 DO - 10.1038/sj.bjc.6602184 ID - Abd El-Rehim2004 ER - TY - JOUR AU - Suo, Z. PY - 2002 DA - 2002// TI - EGFR family expression in breast carcinomas c-erbB-2 and c-erbB-4 receptors have different effects on survival JO - J Pathol VL - 196 UR - https://doi.org/10.1002/path.1003 DO - 10.1002/path.1003 ID - Suo2002 ER -